var eventsData = [{"Ticker":"NLSN","EffectiveDate":"2017-01-10","Type":"RatingNeutral","Title":"Barclays downgrades NLSN to Equal-Weight from Overweight.","DailyReturn":-0.0144,"FiveDayReturnAfter":0.000236,"FiveDayReturnBefore":0.009726},{"Ticker":"NLSN","EffectiveDate":"2016-12-14","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades NLSN to Overweight from Equal-Weight.","DailyReturn":0.02569,"FiveDayReturnAfter":0.0293,"FiveDayReturnBefore":-0.008527},{"Ticker":"NLSN","EffectiveDate":"2016-12-06","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on NLSN to Hold. Target Price is $48.","DailyReturn":-0.000236,"FiveDayReturnAfter":-0.005675,"FiveDayReturnBefore":-0.023536},{"Ticker":"NLSN","EffectiveDate":"2016-12-05","Type":"RatingNeutral","Title":"Barclays maintains NLSN to Overweight. Target Price is $50; previously $55.","DailyReturn":0.008082,"FiveDayReturnAfter":0.015334,"FiveDayReturnBefore":-0.031125},{"Ticker":"NLSN","EffectiveDate":"2016-11-18","Type":"Dividend","Title":"The Firm pays dividend $0.31","DailyReturn":-0.017738,"FiveDayReturnAfter":-0.000231,"FiveDayReturnBefore":-0.025966},{"Ticker":"NLSN","EffectiveDate":"2016-11-17","Type":"RatingNeutral","Title":"Citigroup assumes NLSN to Neutral. Target Price is $45.","DailyReturn":-0.02039,"FiveDayReturnAfter":-0.027536,"FiveDayReturnBefore":-0.011143},{"Ticker":"NLSN","EffectiveDate":"2016-11-16","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on NLSN to Buy. Target Price is $50.","DailyReturn":0.024094,"FiveDayReturnAfter":-0.008378,"FiveDayReturnBefore":-0.024258},{"Ticker":"NLSN","EffectiveDate":"2016-11-15","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on NLSN to Buy. Target Price is $50.","DailyReturn":0.011841,"FiveDayReturnAfter":-0.004093,"FiveDayReturnBefore":-0.036029},{"Ticker":"NLSN","EffectiveDate":"2016-10-25","Type":"EarningsRevenueMiss","Title":"Before market open, NLSN reports 2016 Q3's earning $0.74 per share and revenue $1570MM. This misses analyst's estimated EPS $0.76, misses estimated revenue $1590MM.","DailyReturn":-0.168942,"FiveDayReturnAfter":-0.198953,"FiveDayReturnBefore":0.026939},{"Ticker":"NLSN","EffectiveDate":"2016-09-15","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on NLSN to Hold.","DailyReturn":0.012531,"FiveDayReturnAfter":0.008829,"FiveDayReturnBefore":-0.028506},{"Ticker":"NLSN","EffectiveDate":"2016-08-25","Type":"RatingNeutral","Title":"Macquarie initiates coverage on NLSN to Outperform. Target Price is $61.","DailyReturn":0.002287,"FiveDayReturnAfter":0.015129,"FiveDayReturnBefore":-0.004988},{"Ticker":"NLSN","EffectiveDate":"2016-08-23","Type":"Dividend","Title":"The Firm pays dividend $0.31","DailyReturn":-0.005079,"FiveDayReturnAfter":-0.00926,"FiveDayReturnBefore":0.010151},{"Ticker":"NLSN","EffectiveDate":"2016-07-27","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $64; previously $60.","DailyReturn":-0.002583,"FiveDayReturnAfter":-0.018439,"FiveDayReturnBefore":-0.003501},{"Ticker":"NLSN","EffectiveDate":"2016-07-26","Type":"RevenueBeat","Title":"Before market open, NLSN reports 2016 Q2's earning $0.71 per share and revenue $1596MM. This meets analyst's estimated EPS $0.71, misses estimated revenue $1610MM.","DailyReturn":-0.018653,"FiveDayReturnAfter":-0.031831,"FiveDayReturnBefore":0.021785},{"Ticker":"NLSN","EffectiveDate":"2016-07-22","Type":"RatingNeutral","Title":"BMO Capital downgrades NLSN to Market Perform from Outperform.","DailyReturn":0.007037,"FiveDayReturnAfter":-0.023183,"FiveDayReturnBefore":0.0254},{"Ticker":"NLSN","EffectiveDate":"2016-05-31","Type":"Dividend","Title":"The Firm pays dividend $0.31","DailyReturn":-0.000374,"FiveDayReturnAfter":0.016527,"FiveDayReturnBefore":0.028702},{"Ticker":"NLSN","EffectiveDate":"2016-04-20","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2016 Q1's earning $0.51 per share and revenue $1487MM. This beats analyst's estimated EPS $0.5, misses estimated revenue $1490MM.","DailyReturn":-0.020385,"FiveDayReturnAfter":-0.037384,"FiveDayReturnBefore":0.01984},{"Ticker":"NLSN","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $59; previously $52.","DailyReturn":-0.006271,"FiveDayReturnAfter":0.010775,"FiveDayReturnBefore":-0.003414},{"Ticker":"NLSN","EffectiveDate":"2016-03-22","Type":"RatingNeutral","Title":"Sterne Agee CRT initiates coverage on NLSN to Buy.","DailyReturn":-0.004038,"FiveDayReturnAfter":0.007089,"FiveDayReturnBefore":0.019023},{"Ticker":"NLSN","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"Morgan Stanley downgrades NLSN to Equal-Weight from Overweight. Target Price is $52.","DailyReturn":-0.00939,"FiveDayReturnAfter":-0.001173,"FiveDayReturnBefore":0.010225},{"Ticker":"NLSN","EffectiveDate":"2016-03-01","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":0.010787,"FiveDayReturnAfter":0.035326,"FiveDayReturnBefore":0.017838},{"Ticker":"NLSN","EffectiveDate":"2016-02-29","Type":"RatingNeutral","Title":"Jefferies initiates coverage on NLSN to Buy. Target Price is $58.","DailyReturn":0.011859,"FiveDayReturnAfter":0.044605,"FiveDayReturnBefore":0.033937},{"Ticker":"NLSN","EffectiveDate":"2016-02-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $51; previously $50.","DailyReturn":-0.000845,"FiveDayReturnAfter":0.015931,"FiveDayReturnBefore":0.013399},{"Ticker":"NLSN","EffectiveDate":"2015-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":0.006752,"FiveDayReturnAfter":-0.006139,"FiveDayReturnBefore":0.010333},{"Ticker":"NLSN","EffectiveDate":"2015-09-02","Type":"RatingNeutral","Title":"Bernstein maintains NLSN to Outperform. Target Price is $55; previously $54.","DailyReturn":0.041313,"FiveDayReturnAfter":0.05926,"FiveDayReturnBefore":0.017831},{"Ticker":"NLSN","EffectiveDate":"2015-08-25","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":-0.013143,"FiveDayReturnAfter":0.041992,"FiveDayReturnBefore":-0.102471},{"Ticker":"NLSN","EffectiveDate":"2015-08-10","Type":"RatingUpgrade","Title":"BMO Capital upgrades NLSN to Outperform from Market Perform. Target Price is $53; previously $46.","DailyReturn":0.033369,"FiveDayReturnAfter":0.043393,"FiveDayReturnBefore":-0.042362},{"Ticker":"NLSN","EffectiveDate":"2015-07-29","Type":"RatingNeutral","Title":"Barclays maintains NLSN to Overweight. Target Price is $53; previously $50.","DailyReturn":0.024163,"FiveDayReturnAfter":0.01619,"FiveDayReturnBefore":0.040002},{"Ticker":"NLSN","EffectiveDate":"2015-07-29","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $48; previously $47.","DailyReturn":0.024163,"FiveDayReturnAfter":0.01619,"FiveDayReturnBefore":0.040002},{"Ticker":"NLSN","EffectiveDate":"2015-06-02","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":0.003816,"FiveDayReturnAfter":-0.005626,"FiveDayReturnBefore":-0.022279},{"Ticker":"NLSN","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $47; previously $46.","DailyReturn":0.004555,"FiveDayReturnAfter":-0.01486,"FiveDayReturnBefore":0.01486},{"Ticker":"NLSN","EffectiveDate":"2015-04-13","Type":"RatingNeutral","Title":"Pivotal Research downgrades NLSN to Hold from Buy. Target Price is $49.","DailyReturn":-0.011085,"FiveDayReturnAfter":-0.039909,"FiveDayReturnBefore":0.010486},{"Ticker":"NLSN","EffectiveDate":"2015-04-09","Type":"RatingNeutral","Title":"Telsey Advisory Group initiates coverage on NLSN to Outperform. Target Price is $53.","DailyReturn":0.004604,"FiveDayReturnAfter":-0.004176,"FiveDayReturnBefore":0.023065},{"Ticker":"NLSN","EffectiveDate":"2015-03-03","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.002908,"FiveDayReturnAfter":-0.012381,"FiveDayReturnBefore":-0.015015},{"Ticker":"NLSN","EffectiveDate":"2015-02-13","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $49; previously $50.","DailyReturn":0.046362,"FiveDayReturnAfter":0.038496,"FiveDayReturnBefore":-0.009367},{"Ticker":"NLSN","EffectiveDate":"2015-02-06","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $46; previously $47.","DailyReturn":-0.011369,"FiveDayReturnAfter":-0.009367,"FiveDayReturnBefore":-0.008153},{"Ticker":"NLSN","EffectiveDate":"2015-02-06","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $50; previously $51.","DailyReturn":-0.011369,"FiveDayReturnAfter":-0.009367,"FiveDayReturnBefore":-0.008153},{"Ticker":"NLSN","EffectiveDate":"2014-12-11","Type":"RatingNeutral","Title":"Credit Suisse maintains NLSN to Outperform. Target Price is $52; previously $56.","DailyReturn":-0.016221,"FiveDayReturnAfter":0.000685,"FiveDayReturnBefore":0.000228},{"Ticker":"NLSN","EffectiveDate":"2014-12-10","Type":"RatingNeutral","Title":"Morgan Stanley maintains NLSN to Overweight. Target Price is $53; previously $52.","DailyReturn":-0.030994,"FiveDayReturnAfter":-0.037902,"FiveDayReturnBefore":0.078972},{"Ticker":"NLSN","EffectiveDate":"2014-11-21","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.003413,"FiveDayReturnAfter":0.018119,"FiveDayReturnBefore":-0.027012},{"Ticker":"NLSN","EffectiveDate":"2014-10-27","Type":"RatingNeutral","Title":"Barclays maintains NLSN to Overweight. Target Price is $50; previously $55.","DailyReturn":-0.002837,"FiveDayReturnAfter":0.00448,"FiveDayReturnBefore":0.006404},{"Ticker":"NLSN","EffectiveDate":"2014-10-24","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $48; previously $52.","DailyReturn":0.011478,"FiveDayReturnAfter":-0.010095,"FiveDayReturnBefore":0.005514},{"Ticker":"NLSN","EffectiveDate":"2014-10-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $46; previously $50.","DailyReturn":0.002855,"FiveDayReturnAfter":0.006404,"FiveDayReturnBefore":0.007883},{"Ticker":"NLSN","EffectiveDate":"2014-10-14","Type":"RatingUpgrade","Title":"Bernstein upgrades NLSN to Outperform from Market Perform. Target Price is $49; previously $51.","DailyReturn":0.006452,"FiveDayReturnAfter":0.007143,"FiveDayReturnBefore":-0.025245},{"Ticker":"NLSN","EffectiveDate":"2014-10-10","Type":"RatingUpgrade","Title":"Pivotal Research upgrades NLSN to Buy from Hold. Target Price is $50; previously $48.","DailyReturn":0.00993,"FiveDayReturnAfter":0.007241,"FiveDayReturnBefore":-0.057185},{"Ticker":"NLSN","EffectiveDate":"2014-08-26","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.00467,"FiveDayReturnAfter":-0.007884,"FiveDayReturnBefore":-0.016127},{"Ticker":"NLSN","EffectiveDate":"2014-07-17","Type":"RatingNeutral","Title":"Pivotal Research downgrades NLSN to Hold from Buy.","DailyReturn":-0.015052,"FiveDayReturnAfter":-0.003511,"FiveDayReturnBefore":-0.007599},{"Ticker":"NLSN","EffectiveDate":"2014-06-19","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $53; previously $51.","DailyReturn":0.004014,"FiveDayReturnAfter":0.018838,"FiveDayReturnBefore":0.002749},{"Ticker":"NLSN","EffectiveDate":"2014-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.013006,"FiveDayReturnAfter":-0.001679,"FiveDayReturnBefore":0.00712},{"Ticker":"NLSN","EffectiveDate":"2014-05-14","Type":"RatingNeutral","Title":"Barclays initiates coverage on NLSN to Overweight. Target Price is $55.","DailyReturn":-0.000422,"FiveDayReturnAfter":-0.007204,"FiveDayReturnBefore":0.005506},{"Ticker":"NLSN","EffectiveDate":"2014-04-25","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $50; previously $48.","DailyReturn":-0.00152,"FiveDayReturnAfter":0.024026,"FiveDayReturnBefore":0.041899},{"Ticker":"NLSN","EffectiveDate":"2014-04-25","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $51; previously $49.","DailyReturn":-0.00152,"FiveDayReturnAfter":0.024026,"FiveDayReturnBefore":0.041899},{"Ticker":"NLSN","EffectiveDate":"2014-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":0.014474,"FiveDayReturnAfter":-0.000864,"FiveDayReturnBefore":-0.004721},{"Ticker":"NLSN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Baird initiates coverage on NLSN to Neutral. Target Price is $50.","DailyReturn":-0.00194,"FiveDayReturnAfter":0.00901,"FiveDayReturnBefore":0.016515},{"Ticker":"NLSN","EffectiveDate":"2014-02-20","Type":"RatingNeutral","Title":"Baird initiates coverage on NLSN to Neutral. Target Price is $50.","DailyReturn":0.000431,"FiveDayReturnAfter":0.00043,"FiveDayReturnBefore":0.030206},{"Ticker":"NLSN","EffectiveDate":"2014-02-13","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on NLSN to Outperform.","DailyReturn":-0.008107,"FiveDayReturnAfter":0.016515,"FiveDayReturnBefore":0.071751},{"Ticker":"NLSN","EffectiveDate":"2014-02-13","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2013 Q4's earning $0.71 per share and revenue $1610MM. This beats analyst's estimated EPS $0.7, misses estimated revenue $1620MM.","DailyReturn":-0.008107,"FiveDayReturnAfter":0.016515,"FiveDayReturnBefore":0.071751},{"Ticker":"NLSN","EffectiveDate":"2014-02-06","Type":"RatingNeutral","Title":"Deutsche Bank assumes NLSN to Buy. Target Price is $48.","DailyReturn":0.023776,"FiveDayReturnAfter":0.071751,"FiveDayReturnBefore":0.00685},{"Ticker":"NLSN","EffectiveDate":"2014-02-04","Type":"RatingUpgrade","Title":"Pivotal Research upgrades NLSN to Buy from Hold. Target Price is $48.","DailyReturn":0.026072,"FiveDayReturnAfter":0.095,"FiveDayReturnBefore":-0.041056},{"Ticker":"NLSN","EffectiveDate":"2013-12-16","Type":"RatingNeutral","Title":"BMO Capital downgrades NLSN to Market Perform from Outperform. Target Price is $45; previously $43.","DailyReturn":0.0,"FiveDayReturnAfter":-0.005936,"FiveDayReturnBefore":0.046437},{"Ticker":"NLSN","EffectiveDate":"2013-12-13","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $49; previously $42.","DailyReturn":0.061918,"FiveDayReturnAfter":0.049278,"FiveDayReturnBefore":0.00607},{"Ticker":"NLSN","EffectiveDate":"2013-12-11","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on NLSN to Outperform. Target Price is $52.","DailyReturn":-0.002993,"FiveDayReturnAfter":0.038842,"FiveDayReturnBefore":0.017418},{"Ticker":"NLSN","EffectiveDate":"2013-11-21","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":-0.001986,"FiveDayReturnAfter":0.063467,"FiveDayReturnBefore":0.007438},{"Ticker":"NLSN","EffectiveDate":"2013-10-29","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on NLSN to Outperform. Target Price is $44.","DailyReturn":0.014381,"FiveDayReturnAfter":0.022346,"FiveDayReturnBefore":0.006698},{"Ticker":"NLSN","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $41; previously $40.","DailyReturn":0.01802,"FiveDayReturnAfter":0.020678,"FiveDayReturnBefore":0.029955},{"Ticker":"NLSN","EffectiveDate":"2013-10-01","Type":"RatingNeutral","Title":"JP Morgan assumes NLSN to Overweight. Target Price is $43.","DailyReturn":0.018656,"FiveDayReturnAfter":-0.006606,"FiveDayReturnBefore":0.001923},{"Ticker":"NLSN","EffectiveDate":"2013-09-20","Type":"RatingNeutral","Title":"Goldman Sachs assumes NLSN to Neutral. Target Price is $38.","DailyReturn":-0.035234,"FiveDayReturnAfter":-0.017911,"FiveDayReturnBefore":0.042021},{"Ticker":"NLSN","EffectiveDate":"2013-09-20","Type":"RatingNeutral","Title":"Bernstein downgrades NLSN to Market Perform from Outperform. Target Price is $40; previously $38.","DailyReturn":-0.035234,"FiveDayReturnAfter":-0.017911,"FiveDayReturnBefore":0.042021},{"Ticker":"NLSN","EffectiveDate":"2013-08-26","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":0.01329,"FiveDayReturnAfter":0.018725,"FiveDayReturnBefore":0.039829},{"Ticker":"NLSN","EffectiveDate":"2013-08-20","Type":"RatingUpgrade","Title":"Bernstein upgrades NLSN to Outperform from Market Perform.","DailyReturn":0.034101,"FiveDayReturnAfter":0.058546,"FiveDayReturnBefore":-0.026376},{"Ticker":"NLSN","EffectiveDate":"2013-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.007704,"FiveDayReturnAfter":0.014707,"FiveDayReturnBefore":-0.016671},{"Ticker":"NLSN","EffectiveDate":"2013-04-29","Type":"RatingNeutral","Title":"Northland Securities initiates coverage on NLSN to Underperform. Target Price is $28.","DailyReturn":-0.014681,"FiveDayReturnAfter":0.025576,"FiveDayReturnBefore":-0.006027},{"Ticker":"NLSN","EffectiveDate":"2013-04-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2013 Q1's earning $0.38 per share and revenue $1380MM. This beats analyst's estimated EPS $0.36, misses estimated revenue $1400MM.","DailyReturn":0.007565,"FiveDayReturnAfter":0.027265,"FiveDayReturnBefore":-0.016736},{"Ticker":"NLSN","EffectiveDate":"2013-04-19","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on NLSN to Outperform. Target Price is $41.","DailyReturn":0.006624,"FiveDayReturnAfter":-0.002596,"FiveDayReturnBefore":-0.031749},{"Ticker":"NLSN","EffectiveDate":"2013-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.00059,"FiveDayReturnAfter":0.02908,"FiveDayReturnBefore":0.054001},{"Ticker":"NLSN","EffectiveDate":"2013-02-15","Type":"RatingNeutral","Title":"Benchmark maintains NLSN to Buy. Target Price is $38; previously $36.","DailyReturn":-0.004608,"FiveDayReturnAfter":-0.008949,"FiveDayReturnBefore":-0.004904},{"Ticker":"NLSN","EffectiveDate":"2013-02-12","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $38; previously $35.","DailyReturn":0.018059,"FiveDayReturnAfter":0.000612,"FiveDayReturnBefore":0.021659},{"Ticker":"NLSN","EffectiveDate":"2013-02-12","Type":"RatingNeutral","Title":"Credit Suisse maintains NLSN to Outperform. Target Price is $38; previously $35.","DailyReturn":0.018059,"FiveDayReturnAfter":0.000612,"FiveDayReturnBefore":0.021659},{"Ticker":"NLSN","EffectiveDate":"2013-02-11","Type":"EarningsBeatRevenueMiss","Title":"After market close, NLSN reports 2012 Q4's earning $0.62 per share and revenue $1460MM. This beats analyst's estimated EPS $0.59, misses estimated revenue $1480MM.","DailyReturn":-0.004267,"FiveDayReturnAfter":-0.012575,"FiveDayReturnBefore":0.008263},{"Ticker":"NLSN","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"Pivotal Research maintains NLSN to Hold. Target Price is $33; previously $31.","DailyReturn":0.011542,"FiveDayReturnAfter":-0.000963,"FiveDayReturnBefore":0.028619},{"Ticker":"NLSN","EffectiveDate":"2012-12-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $41; previously $36.","DailyReturn":-0.01229,"FiveDayReturnAfter":-0.018277,"FiveDayReturnBefore":0.050067},{"Ticker":"NLSN","EffectiveDate":"2012-11-28","Type":"RatingNeutral","Title":"Pivotal Research initiates coverage on NLSN. Target Price is $31.","DailyReturn":0.00392,"FiveDayReturnAfter":0.014857,"FiveDayReturnBefore":0.013636},{"Ticker":"NLSN","EffectiveDate":"2012-10-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $36; previously $35.","DailyReturn":-0.021248,"FiveDayReturnAfter":-0.02493,"FiveDayReturnBefore":-0.042911},{"Ticker":"NLSN","EffectiveDate":"2012-10-22","Type":"EarningsRelease","Title":"Before market open, NLSN reports 2012 Q3's earning $0.29 per share and revenue $1351MM..","DailyReturn":-0.057234,"FiveDayReturnAfter":-0.083867,"FiveDayReturnBefore":0.021859},{"Ticker":"NLSN","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Goldman Sachs maintains NLSN to Buy. Target Price is $36; previously $35.","DailyReturn":0.005616,"FiveDayReturnAfter":0.043001,"FiveDayReturnBefore":0.001655},{"Ticker":"NLSN","EffectiveDate":"2012-08-09","Type":"RatingNeutral","Title":"Goldman Sachs maintains NLSN to Buy. Target Price is $35; previously $33.","DailyReturn":0.013273,"FiveDayReturnAfter":-0.001049,"FiveDayReturnBefore":0.0035},{"Ticker":"NLSN","EffectiveDate":"2012-07-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2012 Q2's earning $0.42 per share and revenue $1390MM. This beats analyst's estimated EPS $0.41, misses estimated revenue $1400MM.","DailyReturn":0.09988,"FiveDayReturnAfter":0.129829,"FiveDayReturnBefore":-0.039943},{"Ticker":"NLSN","EffectiveDate":"2012-07-18","Type":"RatingNeutral","Title":"PiperJaffray maintains NLSN to Neutral. Target Price is $26; previously $28.","DailyReturn":-0.003071,"FiveDayReturnAfter":-0.039943,"FiveDayReturnBefore":-0.011451},{"Ticker":"NLSN","EffectiveDate":"2012-04-25","Type":"EarningsRelease","Title":"Before market open, NLSN reports 2012 Q1's earning $0.07 per share and revenue $1334MM..","DailyReturn":-0.003416,"FiveDayReturnAfter":-0.005137,"FiveDayReturnBefore":0.004794},{"Ticker":"NLSN","EffectiveDate":"2012-03-21","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $37; previously $34.","DailyReturn":-0.004244,"FiveDayReturnAfter":-0.010834,"FiveDayReturnBefore":0.028143}];